ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 621326 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 621326; 2) Community: the network communities that were significantly associated with the response to NSC 621326; 3) Molecule: the relationships between components within communities and NSC 621326; 4) MDR: the compounds that were significantly associated with the NSC 621326.

NSC Compound Enrichment Correlation
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.0339770934764508 0.18448909
NSC 750440 Null 0.0339770934764508 0.18577071
NSC 756166 GSK312948A 0.0339770934764508 0.29381519
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0339770934764508 0.3763595
NSC 143925 Pekilocerin A 0.0339770934764511 0.029528926
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0339770934764511 0.13103846
NSC 382002 Null 0.0339770934764511 0.2570516
NSC 127128 Null 0.0339770934764516 -0.35509283
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0339770934764516 0.35169044
NSC 276382 PEPLEOMYCIN 0.0339770934764516 -0.1168029
Total:85  Current:60    [First] [Prev] [Next] [Last]